LogoChain
Request Assessment
All Systems Nominal
Chain Ops Center
chain@ops:~$display_status --live

Climate-controlled last-mile transport for vaccines, biologics, and compounded medications. Real-time IoT monitoring. GDP-documented. Zero tolerance for excursions.

99.97%

Excursion-Free

35+

Chains Monitored

<38min

Avg Response

Request Cold Chain AssessmentDownload GDP Checklist
CHN-4471

Chicago → Mayo Clinic, Rochester

ON ROUTE

mRNA Vaccines — 2,400 vials

2.4°C

Internal

42%

Humidity

SEALED

Door

Route ProgressETA 03h 14m
41.8827° N, 87.6233° W68%
24h Temp TraceSTABLE
CHN-4472

Boston → Dana-Farber Cancer Institute

ON ROUTE

Biologic — Pembrolizumab, 180 units

2.3°C

Internal

39%

Humidity

SEALED

Door

Route ProgressETA 01h 52m
42.3601° N, 71.0589° W84%
CHN-4473

San Francisco → UCSF Medical Center

ON ROUTE

Compounded Rx — Sterile Injectables

2.5°C

Internal

44%

Humidity

SEALED

Door

Route ProgressETA 00h 47m
37.7749° N, 122.4194° W93%

Refrigeration Units

ONLINE

GPS Telemetry

ACTIVE

Door Seal Sensors

NOMINAL

Humidity Control

STABLE

GDP Compliant99.97% Excursion-FreeReal-Time IoT MonitoringFDA 21 CFR Part 211USP Chapter 1EU GDP 2013DSCSA SerializationCell & Gene Therapy Capable−80°C to +25°C Range24/7 Ops CenterGDP Compliant99.97% Excursion-FreeReal-Time IoT MonitoringFDA 21 CFR Part 211USP Chapter 1EU GDP 2013DSCSA SerializationCell & Gene Therapy Capable−80°C to +25°C Range24/7 Ops Center

Cold Chain Performance

99.97%

Excursion-free delivery rate across 11,400+ GDP-documented shipments last quarter. The industry average is 80%.

Cold Chain Integrity — Q1 2026
Vaccines & Immunologics99.98%

4,211 shipments

Biologics & mAbs99.96%

3,847 shipments

Cell & Gene Therapies99.94%

812 shipments

Compounded Sterile Rx99.99%

2,530 shipments

Zero Recalled Shipments

No Chain-transported payload has ever been subject to an FDA recall or WHO excursion advisory.

GDP-Compliant Shipments

11,400+

Shipped under 21 CFR Part 211, EU GDP 2013/C 343/01, and USP <1> temperature standards last quarter alone.

Route Density — Last Quarter

Northeast Corridor

3,847 shipments

84%

Midwest Medical Hub

2,914 shipments

64%

Southeast Network

2,403 shipments

53%

West Coast Biotech

1,841 shipments

40%

Central Plains

395 shipments

9%

48

States covered

6h

Max route duration

Average Deviation Response

<38min

From first sensor alert to confirmed stabilization. Industry benchmark is 4–6 hours. We set a different standard.

Excursion Response Protocol
01

Automated Alert

IoT sensor detects deviation. System triggers alert within 90 seconds. Ops center notified simultaneously.

02

Driver + Ops Mobilization

Driver receives in-cab alert. Ops coordinator initiates protocol call. Nearest qualified service point identified.

03

Corrective Action

Refrigeration unit reset or backup coolant deployed. Temperature stabilized. GPS rerouting if required.

04

Pharmacist Notification

Receiving pharmacy director notified with real-time excursion data. Risk assessment initiated per USP <1> guidelines.

05

GDP Documentation

Full excursion report generated. Temperature log exported. Deviation form filed within 2 hours of resolution.

Cold Chain Assessment

Start with a compliance audit, not a sales call.

Tell us about your payload profile and facility type. We'll map your cold chain risk exposure and identify GDP documentation gaps — at no charge.

1 shipment26–50 shipments / month500+

No commitment required. A Chain compliance specialist will contact you within 1 business day.

GDP Compliance Checklist

42-point audit checklist aligned with EU GDP 2013/C 343/01 and FDA 21 CFR Part 211 for pharmaceutical transport operations.

  • Validated packaging requirements
  • Calibration log templates
  • Excursion documentation forms
  • Driver training checklist
  • Backup power verification
  • Carrier qualification criteria

Regulatory Alignment

FDA21 CFR Part 211
EUGDP 2013/C 343/01
USPChapter ⟨1⟩ Temperature
PDATR-46 Revised 2024
DSCSASerialization Compliant